[Chemotherapy of malignant melanomas].
D000276:Adjuvants, Immunologic; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001500:BCG Vaccine; D003606:Dacarbazine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008207:Lymphatic Metastasis; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000473:pathology; D009163:Mycobacterium bovis; D009362:Neoplasm Metastasis; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D011379:Prognosis; D014750:Vincristine / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D000970:Antineoplastic Agents; D001500:BCG Vaccine; D009607:Nitrosourea Compounds; D014750:Vincristine; D003606:Dacarbazine
Die Chemotherapie des malignen Melanoms.